An Open Label Extension Study of the Efficacy of MORAb-003

Summary

An open label extension of the MORAb-003-002 study in order to continue the active patients in the MORAb-003-002 study on maintenance MORAb-003 infusions after the main study is closed.

Timeline

Start

2010-01-13

Primary completion

2013-03-05

Completion

2013-03-05

Outcome

Outcome not reported

Stopped: “Study was terminated by sponsor due to futile results in NCT00849667 study.”

Drugs

Indications